Similar articles

• Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.

  Medina Santillán R, Reyes-García G, Mateos-García E. Medina Santillán R, et al. Proc West Pharmacol Soc. 2002;45:137-8. Proc West Pharmacol Soc. 2002. PMID: 12434558 Clinical Trial. No abstract available.
• The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.

  Comaschi M, Corsi A, Di Pietro C, Bellatreccia A, Mariz S; COM06 Study Investigators. Comaschi M, et al. Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):373-9. doi: 10.1016/j.numecd.2007.04.003. Epub 2007 Oct 24. Nutr Metab Cardiovasc Dis. 2008. PMID: 17919894 Clinical Trial.
• Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.

  Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ. Cunha MR, et al. Diabetes Obes Metab. 2008 Mar;10(3):238-45. doi: 10.1111/j.1463-1326.2006.00690.x. Diabetes Obes Metab. 2008. PMID: 18269639 Clinical Trial.
• Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.

  Dailey GE. Dailey GE. Expert Opin Pharmacother. 2003 Aug;4(8):1417-30. doi: 10.1517/14656566.4.8.1417. Expert Opin Pharmacother. 2003. PMID: 12877648 Review.
• Glyburide/metformin HCl clinical overview.

  Seymour A. Seymour A. Manag Care. 2001 Feb;10(2 Suppl):11-6. Manag Care. 2001. PMID: 11729403 Review. No abstract available.